LONDON, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Emerging Markets Global Advisory LLP (EMGA) finalized a further financing for Ipak Yuli in Uzbekistan, funded by OeEB, CDP and Allianz Global Investors (AGI)......
BEXLUTRY is the first radioligand equivalent for the treatment of GEP-NETs in adults and the first radioligand therapy from Curium™ approved by the FDA
